ArticlePrzeglad gastroenterologiczny2024
Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020.
Article in Przeglad gastroenterologiczny, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gastric cancer is one of the world's leading causes of death due to oncological diseases. Gastric cancer comprises a diverse group of diseases that includes several oncological units. Aim: To analyse the nosological structure of epidemiological data related to gastric cancer in Ukraine and compare it with global trends from 2003 to 2020. Material and methods: The data were retrieved from the National Cancer Registry of Ukraine and analysed using MedCalc for Windows, version 20.218 (MedCalc Software, Ostend, Belgium). Results: Eight forms of gastric cancer were diagnosed every year. The lowest incidence rate was in 2020, with 8.99 per 100,000 people/year. This was a 33.71% drop compared to 2005 (p < 0.0001). Adenocarcinoma constituted the largest part of the cases over the 2003 to 2020 period: 96.38% (95% CI: 95.02-97.05%). All the other types of gastric cancer together comprised 2.97% (95% CI: 2.34-3.76%) of the cases. The number of adenocarcinoma cases as well as its incidence rate decreased in 2003-2020 in Ukraine. The incidence rate of all types of gastric cancer was seen to decrease over the 2003-2020 timeframe in Ukraine. Adenocarcinoma was the leading form of gastric cancer in the country, and other types were uncommon in both Ukraine and the rest of the world. There was a change in the incidence rates of the other forms of gastric cancer, but those incidences did not notably affect the structure of the epidemiological data. Conclusions: The total number of cases of gastric cancer, as well as its incidence rate, decreased in Ukraine from 2003 to 2020. This situation corresponds with global tendencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.